Development of novel drug particles
Ended Awarded Last action
- Contract number
- HT942524F0292
- Awardee
-
Crititech Particle Engineering Solutions, LLC UEI QMLLX81RZ6V9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $109,996
Award facts
- Opportunity
-
- HT942524R0116 Solicitation number
- Contract value 100% obligated
- $109,995.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Lawrence, KS 66044, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $109,995.75 firm fixed-price delivery order to Crititech Particle Engineering Solutions, LLC on September 9, 2024, for the development of novel drug particles. The contract, with an ultimate completion date of September 8, 2025, will be performed at Crititech's facility in Lawrence, Kansas. No set-aside designation was used in this competitive award. Crititech, a pharmaceutical particle engineering manufacturer based in Lawrence, will serve as the prime contractor with no identified major subcontractors.
This delivery order is issued under Crititech's single-award Indefinite Delivery Contract with the Defense Health Agency, established on the same date with a ceiling value of $709,995.75 and a performance period extending through September 8, 2029. The IDC structure demonstrates the Defense Health Agency's confidence in Crititech's specialized capabilities for particle engineering and indicates the agency's intention to maintain an ongoing relationship for supporting medical and healthcare innovation objectives within the Department of Defense. The contracting approach reflects open competition principles and positions Crititech as a primary resource for the agency's pharmaceutical particle engineering requirements over the multi-year period.
Quick answers
Who was awarded contract HT942524F0292?
HT942524F0292 was awarded to Crititech Particle Engineering Solutions, LLC by Defense Health Agency (Department of Defense) on September 9, 2024.
How much is contract HT942524F0292 worth?
The government has obligated $109,996 on HT942524F0292.
Is contract HT942524F0292 an order under another contract?
Yes. HT942524F0292 is a delivery order under HT942524D0011, an indefinite delivery contract.
Was contract HT942524F0292 competed?
The extent of competition for HT942524F0292 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award